The choppy waters of this year’s market have forced a significant slowdown in digital health investment, but buyers and builders alike are seizing the moment to consider mergers and acquisitions as strategic opportunities, Rock Health reports. Big ticket M&A deals dominated 2022’s healthcare news cycle, while valuation declines, customer overwhelm, and an unfriendly IPO market continue to raise expectations for growing digital health M&A activity — even compelling one company to issue a statement swatting down acquisition rumors.
Rock Health in the article explores the sell-side and buy-side dynamics that are making conditions ripe for M&A activity and dig into four M&A approaches being pursued by acquirers in this market moment. They share recent examples for each approach, with an eye toward what each one reveals about the digital health sector today and how it might change over the next few quarters. Read more.
